Dimensional Fund Advisors
CTSO icon

Dimensional Fund Advisors’s Cytosorbents Corp CTSO Stock Holding History

Dimensional Fund Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,829
Closed -$62.7K – 3400
2023
Q4 		$62.7K Sell
2,829
-1,144
-29% -$34K ﹤0.01% 3333
2023
Q3 		$149K Sell
3,973
-328
-8% -$18.8K ﹤0.01% 3260
2023
Q2 		$309K Hold
4,301
– – ﹤0.01% 3151
2023
Q1 		$290K Buy
+4,301
New +$258K ﹤0.01% 3129
2022
Q3 		$149K Sell
5,482
-3,799
-41% -$148K ﹤0.01% 3283
2022
Q2 		$407K Sell
9,281
-2,966
-24% -$136K ﹤0.01% 3108
2022
Q1 		$781K Sell
12,247
-237
-2% -$17K ﹤0.01% 3049
2021
Q4 		$1.05M Buy
12,484
+1,341
+12% +$150K ﹤0.01% 3023
2021
Q3 		$1.81M Buy
11,143
+8,069
+262% +$1.31M ﹤0.01% 2882
2021
Q2 		$464K Buy
+3,074
New +$518K ﹤0.01% 3177

Other funds holding CTSO

Avenir Corporation
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Granahan Investment Management
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Skylands Capital
Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Dimensional Fund Advisors's CTSO Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2024, closing a stake of 2,829 shares — an estimated $62.7K sold.

Dimensional Fund Advisors first reported a position in CTSO in Q2 2021 and held it in 10 quarters. The position peaked at $1.81M in Q3 2021. 48 funds tracked by Wall St. Rank hold CTSO as of Q1 2024.

  • Dimensional Fund Advisors reported no remaining Cytosorbents Corp position as of Q1 2024 after selling out during the quarter.
  • Dimensional Fund Advisors sold 2,829 Cytosorbents Corp shares in Q1 2024, an estimated $62.7K.
  • Dimensional Fund Advisors first reported a position in Cytosorbents Corp in Q2 2021 and held it in 10 quarters.
  • Dimensional Fund Advisors's Cytosorbents Corp position peaked at $1.81M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.